EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Analysis of the LncRNA ‐Mediated ceRNA Network Associated With Prognosis in Posttreatment Recurrent Nasopharyngeal Carcinoma

Qihong Liu iD, Jingxiao Lu, Zhiqiang Wang, Qingming Li, Jianhui Wu, Kexing Lyu, Beiping Miao, Wenbin Lei, Guohui Nie iD, Xiaoqin Fan iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Qihong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, P.R. China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Nasopharyngeal Carcinoma, Gene Regulatory Networks, Neoplasm Recurrence, Local. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, The Medical-Engineering Interdisciplinary Research Foundation of ShenZhen University, Futian Healthcare Research Project of ShenZhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The competing endogenous RNA hypothesis offers new insights into tumour progression, yet its role in posttreatment nasopharyngeal carcinoma relapse remains unclear. This study constructed ceRNA networks to identify molecular markers associated with NPC relapse. Three pairs of primary and relapse NPC tissue samples, along with their matched adjacent tissues, were collected for the RNA and miRNA sequencing, screened and identified relapse‐related specific differentially expressed genes. We identified relapse‐specific differentially expressed genes and functional analyses revealed enrichment in translation, biosynthesis, metabolism, TCA cycle, cell cycle, p53 signalling and immune pathways. Then these relapse‐associated differentially expressed mRNAs, lncRNAs, and miRNAs were utilised to construct regulatory networks, resulting in a ceRNA network comprising 813 mRNAs, 143 lncRNAs, and 24 miRNAs, along with a survival‐associated subnetwork of 23 mRNAs. Key mRNAs, such as UBC, PLA2R1, PTPRO, SMC5, PFN2, TIMM17B, NT5E and PCSK5, were validated via qPCR in NPC cell lines and tissues. To our knowledge, this is the first study to construct a comprehensive ceRNA network specifically for posttreatment recurrent NPC. These findings highlight the ceRNA network as a valuable framework for elucidating the mechanisms of NPC relapse and for identifying potential biomarkers for prognosis and therapeutic targets in recurrent nasopharyngeal carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingNasopharyngeal CarcinomaGene Regulatory NetworksNeoplasm Recurrence, LocalNasopharyngeal NeoplasmsHumansPrognosisGene Expression Regulation, NeoplasticBiomarkers, TumorMicroRNAsRNA, MessengerCell Line, TumorGene Expression ProfilingFemaleMaleRNA, Competitive Endogenous

Stichwörter der Autor:innen

LncRNA sequencingceRNA networkmiRNAnasopharyngeal cancerrelapse

Substanzen

RNA, Long NoncodingBiomarkers, TumorMicroRNAsRNA, MessengerRNA, Competitive Endogenous

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, P.R. China.
  • Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngology, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second P…
  • The Bio-Bank of Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, P.R. China.
  • Department of Otolaryngology, Zhongshan People's Hospital, Zhongshan, Guangdong, P.R. China.
  • Department of Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, National Key Department of Otorhinolaryngology of People's Republic of China, Guangzhou, Guangdong, P.R. China.

ORCID-Profile: Qihong Liu, Guohui Nie, Xiaoqin Fan

Förderung

  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • The Medical-Engineering Interdisciplinary Research Foundation of ShenZhen University
  • Futian Healthcare Research Project of ShenZhen
  • Shenzhen Otorhinolaryngology Clinical Research Center

Zitieren

APA

Liu, Q., Lu, J., Wang, Z., Li, Q., Wu, J., Lyu, K., Miao, B., Lei, W., Nie, G., & Fan, X. (2025). Integrated Analysis of the LncRNA ‐Mediated ceRNA Network Associated With Prognosis in Posttreatment Recurrent Nasopharyngeal Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70973

Vancouver

Liu Q, Lu J, Wang Z, Li Q, Wu J, Lyu K, et al. Integrated Analysis of the LncRNA ‐Mediated ceRNA Network Associated With Prognosis in Posttreatment Recurrent Nasopharyngeal Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70973

BibTeX
@article{Liu2025,
  author = {Liu, Qihong and Lu, Jingxiao and Wang, Zhiqiang and Li, Qingming and Wu, Jianhui and Lyu, Kexing and Miao, Beiping and Lei, Wenbin and Nie, Guohui and Fan, Xiaoqin},
  title = {Integrated Analysis of the LncRNA ‐Mediated ceRNA Network Associated With Prognosis in Posttreatment Recurrent Nasopharyngeal Carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70973}
}
Kostenlos starten →